--- title: egnite at TCT | The evidence behind the next era of cardiovascular care description: Real-world evidence is shaping cardiovascular care. Meet with egnite at TCT October 31 - November 2. image: https://events.egnitehealth.com/hubfs/TCT-social-meet-w-egnite.jpg --- [![Egnite\_Main Logo](https://events.egnitehealth.com/hs-fs/hubfs/Egnite_Main%20Logo.png?width=1600&height=418&name=Egnite_Main%20Logo.png "Egnite_Main Logo")](https://egnitehealth.com/) [Contact us](https://egnitehealth.com/contact-us) # How egnite fuels the science # The evidence behind the next era of cardiovascular care Who should be evaluated, and when? How long will the result last? Real-world data is increasingly shaping the answers. Visit us at Booth 4619 or Conference Suite CS36. ##### Schedule a meeting with egnite Health ## Your guide to research supported by egnite data at TCT ![aortic-stenosis](https://events.egnitehealth.com/hs-fs/hubfs/aortic-stenosis.jpg?width=100&height=100&name=aortic-stenosis.jpg "aortic-stenosis") Moderate Aortic Stenosis with at-risk Features: Outcomes from a Large Real-World Registry Randomized trials are now testing transcatheter aortic valve replacement (TAVR) in patients with moderate aortic stenosis (AS) who have at-risk features. This study looks at the same population in everyday practice: how common are at-risk features in moderate AS, and what happens to these patients when they remain untreated? Presenter: Philippe Généreux, MD, Morristown Medical Center  When: Monday, November 2 at 2:50 p.m. PT at Station 10 Session: TAVR Design and Deployment  [Add session to your schedule](https://events.egnitehealth.com/hubfs/social-suggested-images/TAVR%20Design%20and%20Deployment.ics?hsLang=en) ![mitral-and-tricuspid](https://events.egnitehealth.com/hs-fs/hubfs/mitral-and-tricuspid.jpg?width=100&height=100&name=mitral-and-tricuspid.jpg "mitral-and-tricuspid") Long-Term Durability After Successful M-TEER: Insights from a Large, Real-World Imaging Database Mitral transcatheter edge-to-edge repair (M-TEER) is reaching more patients, at more sites, with greater complexity. The study was selected through egnite’s Call for Science program. Presenter: John T. Saxon, MD, UVA Health When: Saturday, October 31 from 11:15–11:23 a.m. PT at World Connect Theater Session: Worldlink Featured Clinical Research: Transcatheter Mitral & Tricuspid Interventions [Add session to your schedule](https://events.egnitehealth.com/hubfs/social-suggested-images/Worldlink%20Featured%20Clinical%20Research_%20Transcatheter%20Mitral%20%26%20Tricuspid%20Interventions.ics?hsLang=en) ![tavr-icon](https://events.egnitehealth.com/hs-fs/hubfs/tavr-icon.jpg?width=100&height=100&name=tavr-icon.jpg "tavr-icon") Long-Term TAVR Durability in a Large, Real-World Clinical and Echocardiographic Database Presenter: John T. Saxon, MD, UVA Health When: Saturday, October 31 from 7:45 AM — 7:53 a.m. PT at World Connect Theater Session: Worldlink Featured Clinical Research: Hot Topics in Transcatheter Aortic Valve Replacement – In Partnership with the Structural Heart Journal [add session to your schedule](https://events.egnitehealth.com/hubfs/Worldlink%20Featured%20Clinical%20Research_%20Hot%20Topics%20in%20Transcatheter%20Aortic%20Valve%20Replacement%20%E2%80%93%20In%20Partnership%20with%20the%20Structural%20Heart%20Journal.ics?hsLang=en) ## CardioCare turns cardiovascular data into clinical action CardioCare® helps you manage increasingly complex patient populations and growing volumes. ![heart-icon](https://events.egnitehealth.com/hs-fs/hubfs/heart-icon.png?width=117&name=heart-icon.png) ##### 25% structural heart growth1 ![growth-icon](https://events.egnitehealth.com/hs-fs/hubfs/growth-icon.png?width=117&name=growth-icon.png) ##### 21% increase in HFrEF patients prescribed GDMT2 ![TCT-landing-page-clock](https://events.egnitehealth.com/hs-fs/hubfs/TCT-landing-page-clock.jpg?width=117&name=TCT-landing-page-clock.jpg) ##### 25–35% reduction in time to treatment3 ## egnite Registry fuels the science The egnite Registry is a de-identified and longitudinal patient data derived from unified data used daily in patient care. It is built for clinical research and life sciences real-world evidence. ![rwe-patients](https://events.egnitehealth.com/hs-fs/hubfs/rwe-patients.png?width=117&name=rwe-patients.png) ##### 14M+ patients ![echo-report](https://events.egnitehealth.com/hs-fs/hubfs/echo-report.jpg?width=117&name=echo-report.jpg) ##### 6M+ echo reports ![rwe-hospital](https://events.egnitehealth.com/hs-fs/hubfs/rwe-hospital.png?width=117&name=rwe-hospital.png) ##### 800+ facilities ![rwe-clinical-notes](https://events.egnitehealth.com/hs-fs/hubfs/rwe-clinical-notes.png?width=117&name=rwe-clinical-notes.png) ##### 300M+ clinical notes **Deep:** The patient journey across 3+ years, all patients 50+ or \<50 with CV symptoms across care settings.  **Rich:** Unified, multimodal EHR data, specialized for CV care. Echo reports, lab results, and unstructured notes recorded at the point of care.  **Timely:** Data comes from care delivered everyday--de-identified and refreshed monthly. Changes in practice, like adoption after a new therapy or a payment policy change, show up in months rather than years. ## Book a meeting to learn more about the egnite Registry Visit us at Booth 4619 November 1-3 at TCT. [Book a Meeting at TCT](https://events.egnitehealth.com/egnite-at-tct-the-evidence-behind-the-next-era-of-cardiovascular-care#section-1) *The CardioCare platform is not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of cardiovascular diseases.* 1 The median from 17 programs one year after implementation, with “mid-size” meaning they do 100-400 structural heart procedures per year. 2 21% is the highest increase to date and is not an average for every participating facility. 3 “A mid-size health system” treating 223 SAS patients annually – this is just one facility’s result.  [![Egnite\_Main Logo](https://events.egnitehealth.com/hubfs/Egnite_Main%20Logo.png "Egnite_Main Logo")](https://egnitehealth.com/) [Follow us on Linkedin](https://www.linkedin.com/company/egnite-health) [Follow us on Twitter](https://twitter.com/egnitehealth) Copyright © 2026 egnite, Inc. All Rights Reserved.